Scientific Online Resource System

Varna Medical Forum

The distribution of breast cancer among women between the age of 20-65years in some regions in Bulgaria

Katya Eguruze


Breast cancer is responsible for 26.5% of new cas- es of cancer in women in Europe and 17% of deaths in women with malignancies. The risk for this disease in Western Europe is 60% higher than the risk of disease in Eastern Europe. Annual incidence of breast cancer in Western Europe and the United States increases by 1-2%. Only 3 997 new cases of breast carcinoma have been registered in Bulgaria in 2013.

Purpose: To investigate the incidence of breast cancer in women from 20 to 65 years of age in some re- gions of our country.

Material and Methods: 1 102 women living in the districts of Varna, Dobrich, Silistra and Shumen were interviewed, about one third of them living in the vil- lage. The surveyed persons are aged 20-65. The survey covers the period from January 2013 to March 2015. It has developed its own toolkit to conduct a direct anon- ymous poll. Sociological and statistical methods of study were used.

Results and Discussion: The distribution of wom- en by age shows approximately uniformity, about half (45.60%) of respondents said they had secondary and technical secondary education. Of all participants in our study, 83.30% did not have any breast-relat- ed health problems, 12.10% had a benign form, and 4.70% diagnosed breast cancer. In 35.90% of the diag- nosed cases, the detected form was at an early stage, in 30.80% the cancer was in the 2nd clinical stage, and in a total of 33.30% the carcinoma was diagnosed at an advanced and last stage. There is a tendency to in- crease the percentage of women who have had benign or breast cancer with increasing age.


women; carcinoma; cancer; breast; morbidity

Full Text


Гаврилов, Ив., М. Начева. Фамилен рак на млечната жлеза. Диагностика, клиника, профилактика и скринингово проследяване. Изд. „Захарий Стоянов”, София, 2013, 11-26.

Гергов, И. Скрининг и диагностика на карцином на гърдата. – В: Клинично поведение при карцином на гърдата. Учебна книга. Tекстове за продължаващо медицинско обучение, Море, 2013. Под ред. на Д. Калев. Изд. АРТ ТРЕЙСЪР, Варна, 2013, 11-21.

Керековска, А., П. Петрова, Н. Фесчиева. Развитие и съвременни тенденции в управлението на скринингови програми за РМЖ в Европа. Здравен мениджмънт, 6, 2006, 56-61.

Национална болница по онкология. Български национален раков регистър. „Заболяемост от рак в България, 2011“. Издателство „Парадигма”. Том XXII, Volume XXII, София, 2013.

Национална болница по онкология. Български национален раков регистър. „Заболяемост от рак в България, 2013“. Издателство „Парадигма”. Том XXIV, Volume XXIV, София, 2015, 61-62.

Първанова, В., К. Тимчева. Рак на млечната жлеза – ранно откриване и съвременно лечение. Фондация „Център за изследване и политика за жените“, София, 2006, 5-185.

Breast Cancer Facts & Figures 2011-2012. American Cancer Society, Inc. 2011, No. 861011.

Cancer Facts and Figures 2004. Atlanta, Ga:American Cancer Society, 2004. Last accessed December 13, 2004.

European Parliament. Report on breast cancer in the European Union. 2003 (RR-497647EN.doc).

Parcin, D., F. Bray, S. Devesa. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001, 37:4-66.

Sant, M., R. Capocaccia, A. Verdecchia, et al. Survival of woman with breast cancer in Europe: variation with age, year of diagnosis and country. Int J Cancer 1998, 77: 679-83.

Spartt, J., W. Donegan. Cancer of the Breast. Elsevier Science-Saunders (USA), 2002, pp 111-133.



Font Size